Qiagen Announces Significant Shareholding Notification

Qiagen ( (QGEN) ) just unveiled an update.

Qiagen N.V. has announced a notification from the Netherlands Authority for the Financial Markets (AFM) regarding a transaction involving Massachusetts Financial Services Company. The transaction, dated June 9, 2025, involves a significant holding of ordinary shares and voting rights in Qiagen. The notification highlights the distribution of shares and voting rights both directly and indirectly, with Massachusetts Financial Services Company holding a total capital interest of 8.05% and voting rights of 9.99%. This announcement could impact Qiagen’s market positioning by indicating a substantial investment interest in the company, potentially influencing stakeholder perceptions and future strategic decisions.

The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.

More about Qiagen

Qiagen N.V. is a company operating in the life sciences industry, primarily focused on providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company is known for its products that enable customers to gain valuable insights from the building blocks of life, including DNA, RNA, and proteins.

Average Trading Volume: 1,410,745

Technical Sentiment Signal: Strong Buy

Current Market Cap: $10.01B

Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.